Home » Topics » Regulatory » Patents

Patents
RSS

MEK kinase inhibitors for cancer treatment presented by Genentech

Aug. 14, 2009

Wyeth identifies liver X receptor modulators for the treatment of lipoprotein disorders

Aug. 14, 2009

ALK5 inhibitors in early development at Novartis for the treatment of PAH

Aug. 13, 2009

Shanghai Hengrui claims DDP IV inhibitors for the treatment of diabetes

Aug. 13, 2009

Novel vitamin D3 derivatives reported for the treatment of psoriasis

Aug. 13, 2009

S1P1 receptor agonists in development at GSK

Aug. 13, 2009

Sanofi-aventis synthesizes P2Y12 receptor antagonists useful in antiplatelet therapy

Aug. 13, 2009

Kissei describes COMT inhibitors for the treatment of Parkinson's disease

Aug. 13, 2009

Abbott discloses histamine H3 receptor ligands for the treatment of ADHD

Aug. 13, 2009

Selective A2A receptor agonists claimed by PGxHealth for autoimmune conditions

Aug. 12, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...